Prognostic significance of del(20q) in patients with hematological malignancies

Kay, 1966, The chromosomes in polycythaemia vera, Br J Haematol, 12, 507, 10.1111/j.1365-2141.1966.tb00134.x Fenaux, 1996, Cytogenetics of myelodysplastic syndromes, Semin Hematol, 33, 127 Heim, 1992, Cytogenetic analysis in the diagnosis of acute leukemia, Cancer, 70, 1701, 10.1002/1097-0142(19920915)70:4+<1701::AID-CNCR2820701609>3.0.CO;2-S Knuutila, 1994, Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms, Genes Chromosomes Cancer, 10, 95, 10.1002/gcc.2870100204 White, 1994, Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells, Blood, 83, 2809, 10.1182/blood.V83.10.2809.2809 Hollings, 1995, Deletion 20q in association with Philadelphia chromosome positive acute lymphoblastic leukemia: a report of two cases, Cancer Genet Cytogenet, 79, 32, 10.1016/0165-4608(94)00068-M Bench, 2000, Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes, Oncogene, 19, 3902, 10.1038/sj.onc.1203728 Le Beau, 1985, c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders, Proc Natl Acad Sci U S A, 82, 6692, 10.1073/pnas.82.19.6692 Nacheva, 1995, Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes, Cancer Genet Cytogenet, 80, 87, 10.1016/0165-4608(94)00150-A Roulston, 1993, Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20, Blood, 82, 3424 Asimakopoulos, 1994, Molecular analysis of chromosome 20q deletion associated with myeloproliferative disorders and myelodysplastic syndromes, Blood, 84, 3086, 10.1182/blood.V84.9.3086.3086 Hollings, 1994, Molecular heterogeneity at the breakpoints of smaller 20q deletions, Genes Chromosomes Cancer, 11, 21, 10.1002/gcc.2870110105 Wang, 1998, Refinement of the commonly deleted segment in myeloid leukemias with a del(20q), Genes Chromosomes Cancer, 21, 75, 10.1002/(SICI)1098-2264(199802)21:2<75::AID-GCC1>3.0.CO;2-4 Nacheva, 1999, Abnormalities of the long arm of chromosome 20 in myeloid malignancies, Cytogenet Cell Genet, 85, 15 Greenberg, 1997, International scoring system for evaluating prognosis in myelodysplastic syndromes, Blood, 89, 2079, 10.1182/blood.V89.6.2079 1995, ISCN 1995: an international system for human cytogenetic nomenclature (1995) Bench, 1998, Molecular genetics and cytogenetics of myeloproliferative disorders, Baillieres Clin Haematol, 11, 819, 10.1016/S0950-3536(98)80041-3 Aatola, 1992, Clinical significance of the del(20q) chromosome in hematologic disorders, Cancer Genet Cytogenet, 62, 75, 10.1016/0165-4608(92)90043-8 Swolin, 1988, A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course, Blood, 72, 386, 10.1182/blood.V72.2.386.386 Asimakopoulos, 1996, Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders, Br J Haematol, 95, 219, 10.1046/j.1365-2141.1996.d01-1896.x Matteucci, 2003, Different mechanisms lead to a karyotypically identical t(20;21) in myelodysplastic syndrome and in acute myeloid leukemia, Cancer Genet Cytogenet, 140, 13, 10.1016/S0165-4608(02)00622-2 Březinová, 2000, Fluorescence in situ hybridization confirmation of 5q deletions in patients with hematological malignancies, Cancer Genet Cytogenet, 117, 45, 10.1016/S0165-4608(99)00142-9 Michalová, 2002, Prognostic significance of deletion del(5)(q31) and complex chromosomal rearrangements in patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), Hematol J, 3, 191 Campbell, 1994, The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders, Leukemia, 8, 67 Mauritzson, 2001, The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex, Br J Haematol, 113, 347, 10.1046/j.1365-2141.2001.02750.x